Literature DB >> 21464040

Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Tiffany A Wallace1, Damali N Martin, Stefan Ambs.   

Abstract

Cancer incidence and mortality rates show great variations across nations and between population groups. These variations are largely explained by differences in age distribution, diet and lifestyle, access to health care, cultural barriers and exposure to carcinogens and pathogens. Cancers caused by infections are significantly more common in developing than developed countries, and they overproportionally affect immigrant populations in the USA and other countries. The global pattern of cancer is not stagnant. Instead, it is dynamic because of fluctuations in the age distribution of populations, improvements in cancer prevention and early detection in affluent countries and rapid changes in diet and lifestyle in parts of the world. For example, increased smoking rates have caused tobacco-induced cancers to rise in various Asian countries, whereas reduced smoking rates have caused these cancers to plateau or even begin to decline in Western Europe and North America. Some population groups experience a disproportionally high cancer burden. In the USA and the Caribbean, cancer incidence and mortality rates are excessively high in populations of African ancestry when compared with other population groups. The causes of this disparity are multifaceted and may include tumor biological and genetic factors and their interaction with the environment. In this review, we will discuss the magnitude and causes of global cancer health disparities and will, with a focus on African-Americans and selected cancer sites, evaluate the evidence that genetic and tumor biological factors contribute to existing cancer incidence and outcome differences among population groups in the USA.

Entities:  

Mesh:

Year:  2011        PMID: 21464040      PMCID: PMC3149201          DOI: 10.1093/carcin/bgr066

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  310 in total

1.  Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer.

Authors:  Uri Einav; Yuval Tabach; Gad Getz; Assif Yitzhaky; Ugur Ozbek; Ninette Amariglio; Shai Izraeli; Gideon Rechavi; Eytan Domany
Journal:  Oncogene       Date:  2005-09-22       Impact factor: 9.867

2.  Differences in pulmonary functions in various racial groups.

Authors:  M Oscherwitz; S A Edlavitch; T R Baker; T Jarboe
Journal:  Am J Epidemiol       Date:  1972-11       Impact factor: 4.897

3.  PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.

Authors:  V Srikantan; Z Zou; G Petrovics; L Xu; M Augustus; L Davis; J R Livezey; T Connell; I A Sesterhenn; K Yoshino; G S Buzard; F K Mostofi; D G McLeod; J W Moul; S Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  Trends in PSA, age and prostate cancer detection among black and white men from 1990-2006 at a tertiary care center.

Authors:  Jeannette M Potts; Megan Lutz; Esteban Walker; Charles Modlin; Eric Klein
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

5.  Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations.

Authors:  Fang Chen; Daniel O Stram; Loïc Le Marchand; Kristine R Monroe; Laurence N Kolonel; Brian E Henderson; Christopher A Haiman
Journal:  Eur J Hum Genet       Date:  2010-11-24       Impact factor: 4.246

6.  Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer.

Authors:  Arnold L Potosky; Linda C Harlan; Richard S Kaplan; Karen A Johnson; Charles F Lynch
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

7.  Survival in blacks and whites after treatment for localized prostate cancer.

Authors:  J E Fowler; F Terrell
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

Review 8.  Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women.

Authors:  T G Ijaduola; E B Smith
Journal:  J Natl Med Assoc       Date:  1998-09       Impact factor: 1.798

9.  Breast cancer incidence and mortality in a Caribbean population: comparisons with African-Americans.

Authors:  Anselm J Hennis; Ian R Hambleton; Suh-Yuh Wu; Maria Cristina Leske; Barbara Nemesure
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

10.  Racial differences in prostate androgen levels in men with clinically localized prostate cancer.

Authors:  James L Mohler; Kris E Gaston; Dominic T Moore; Michael J Schell; Brian L Cohen; Catharina Weaver; Peter Petrusz
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

View more
  51 in total

1.  Multi-ethnic minority nurses' knowledge and practice of genetics and genomics.

Authors:  Bernice Coleman; Kathleen A Calzone; Jean Jenkins; Carmen Paniagua; Reynaldo Rivera; Oi Saeng Hong; Ida Spruill; Vence Bonham
Journal:  J Nurs Scholarsh       Date:  2014-04-23       Impact factor: 3.176

Review 2.  Global DNA hypomethylation in prostate cancer development and progression: a systematic review.

Authors:  R Zelic; V Fiano; C Grasso; D Zugna; A Pettersson; A Gillio-Tos; F Merletti; L Richiardi
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-11-11       Impact factor: 5.554

3.  ERR1 and PGC1α associated mitochondrial alterations correlate with pan-cancer disparity in African Americans.

Authors:  Danthasinghe Waduge Badrajee Piyarathna; Akhila Balasubramanian; James M Arnold; Stacy M Lloyd; Balasubramanyam Karanam; Patricia Castro; Michael M Ittmann; Nagireddy Putluri; Nora Navone; Jeffrey A Jones; Wendong Yu; Vlad C Sandulache; Andrew G Sikora; George Michailidis; Arun Sreekumar
Journal:  J Clin Invest       Date:  2019-03-28       Impact factor: 14.808

Review 4.  An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines.

Authors:  Julie Dutil; Zhihua Chen; Alvaro N Monteiro; Jamie K Teer; Steven A Eschrich
Journal:  Cancer Res       Date:  2019-03-20       Impact factor: 12.701

Review 5.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

6.  Looking at cancer health disparities without the colored lenses.

Authors:  Mohammad Aslam Khan; Girijesh Kumar Patel; Sanjeev Kumar Srivastava; James Elliot Carter; Jennifer Young Pierce; Rodney Paul Rocconi; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Health Disparities       Date:  2019-08-19

7.  Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/ lymphoma cells.

Authors:  Yahaira Santiago-Vázquez; Umashankar Das; Armando Varela-Ramirez; Sarah T Baca; Yoshira Ayala-Marin; Carolina Lema; Swagatika Das; Alaa Baryyan; Jonathan R Dimmock; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2016

8.  NHLBI integrated pediatric guidelines: battle for a future free of cardiovascular disease.

Authors:  Justin P Zachariah; Sarah D de Ferranti
Journal:  Future Cardiol       Date:  2013-01

9.  History, biology, and health inequities: emergent embodied phenotypes and the illustrative case of the breast cancer estrogen receptor.

Authors:  Nancy Krieger
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

Review 10.  Who and what is a "population"? Historical debates, current controversies, and implications for understanding "population health" and rectifying health inequities.

Authors:  Nancy Krieger
Journal:  Milbank Q       Date:  2012-12       Impact factor: 4.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.